Ovctek China Inc: Shenzhen bourse approves Company's application of non-public offering

NBD AI Bulletin -- Ovctek China Inc (SZ 300595, close price: 66.66 yuan) on September 15 anounced that the Company's application of stock issuance to specific objects was reviewed and approved by the Shenzhen Stock Exchange.

The 2020 annual report shows that the main business of Ovctek China Inc is rigid gas permeable contact lenses, the medical industry, accounting for 92.76%,7.24% of revenue, respectively.

Ovctek China's chairman and general manager is Tao Yuequn, male, 61 years old, Chinese national, doctor of engineering from UCLA.

(By Gao Han)

Disclaimer: The content and data of this article are for reference only and do not constitute investment advice. Please verify before use. Any action you take upon the information on this website is at your own risk.